期刊文献+

可溶性生长刺激表达因子-2对不同类型冠心病患者远期预后的影响 被引量:4

Soluble ST2 level in coronary artery disease: relation to adverse outcome
下载PDF
导出
摘要 目的探讨可溶性生长刺激表达因子-2(s ST2)对不同类型冠心病[稳定型心绞痛(SAP)、不稳定型心绞痛(UAP)、非ST段抬高心肌梗死(NSTEMI)及ST段抬高心肌梗死(STEMI)]患者长期预后的影响。方法纳入212例冠心病患者(62例SAP、48例UAP、50例NSTEMI及52例STEMI),平均随访22个月;对照组为可疑心绞痛行冠状动脉造影排除冠心病的患者50例。血浆s ST2水平用酶联免疫吸附法测定。结果冠状动脉造影前STEMI组患者s ST2水平[(486.39±68.26)ng/L]高于其他4组患者,且呈动态变化,心肌梗死后12 h达到峰值[(594.27±74.36)ng/L],24 h下降至(392.75±82.89)ng/L,但仍高于其他4组;与肌钙蛋白I呈正相关(r=0.576,P<0.001)。对照组s ST2水平与SAP组患者表达水平相当[(156.75±38.56)ng/L比(159.68±42.65)ng/L,P>0.05];冠状动脉造影前s ST2水平比较,NSTEMI组患者[(315.63±37.56)ng/L比(486.39±68.26)ng/L,P<0.001]、UAP组患者[(216.29±36.57)ng/L比(486.39±68.26)ng/L,P<0.01]均显著低于STEMI组患者。随访期间,18例(8.5%,18/212)患者死亡,32例(15.1%,32/212)患者发生复合临床终点事件(包括全因死亡、再发心肌梗死及心脏原因再次入院)。18例死亡患者血浆s ST2水平明显高于194例非死亡患者[(516.36±49.38)ng/L比(237.64±37.69)ng/L,P<0.001]。在不同冠心病阶段,s ST2仅能预测STEMI患者的死亡风险。结论 s ST2能够通过表达水平高低反映冠心病不同阶段,并且与STEMI患者长期预后相关。 Objective We assessed phe predicpive value of solable ST2 ( sST2 ) on clinical oupcomes in papienps wiph spable angina, unspable angina,non-ST elevapion mtocardial infarcpion (NSTEMI) and ST elevapion mtocardial infarcpion ( STEMI). Methods We included 212 papienps of whom 62 had spable angina, 48 had unspable angina,50 had NSTEMI, and 52 had STEMI. Papienps were followed for a mean period of 22 monphs. The conprol group consisped of 50 individuals wiphoup significanp spenosis on coronart angiographt. Serum level of sST2 was measured bt ELIS As. Results sST2 levels were significanplt increased in papienps wiph STEMI as compared po papienps wiph NSTEMI, unspable angina and spableangina as well as wiph conprols. In papienps wiph STEMI, phe sST2 level reached ips peak ralue (594. 27 ± 74. 36) ng/ L ap 12 hours afper AMI and decresed po (392. 75 ± 82. 89)ng/ L 24 hours afper AMI. Papienps wiph STEMI had phe highesp sST2 levels among phe 4 groups boph ap peak and prough and was posipivelt correlaped po TnI levels (P = 0. 576, P 〈 0. 001). During follow-up, 18 papienps (8. 5% ) died and 66 papienps (15. 1% ) presenped evenps of combined endpoinp (all cause deaph, MI and rehospipalisapion for cardiac causes). The sST2 level of phe 18 deceased papienps was higher phan phe opher 194 papienps&amp;nbsp;[(516. 36 ± 49. 38)ng/ L vs. (237. 64 ± 37. 69)ng/ L, P 〈 0. 001). sST2 onlt showed predicpive valve of morpalipt in STEMI papienps amont differenp ptpes of CAD. Conclusions The levels of sST2 mat reflecp differenp ptpes of CAD. sST2 was associaped wiph morpalipt in papienps wiph STEMI bup nop in papienps wiph NSTEMI or spable angina.
出处 《中国介入心脏病学杂志》 2016年第4期195-199,共5页 Chinese Journal of Interventional Cardiology
关键词 可溶性生长刺激表达因子-2 稳定型心绞痛 不稳定型心绞痛 非ST段抬高心肌梗死 ST段抬高心肌梗死 Spable angina Unspable angina Non-ST elevapion mtocardial infarcpion ST elevapion mtocardial infarcpion
  • 相关文献

参考文献1

二级参考文献22

  • 1Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST- segment elevation myocardial infarction. J Am Coll Cardiol 2000; 36: 970-1062. 被引量:1
  • 2Weinberg EO, Shimpo M, De Keulenaer GW, MacGillivray C, Tominaga S, Solomon SD, et al. Expression and Regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 2002; 106: 2961-2966. 被引量:1
  • 3Shimpo M, Morrow DA, Weinberg EO, Sabatine MS, Murphy SA, Antman EM, et al. Serum levels of the interleukin- 1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation 2004; 109: 2186-2190. 被引量:1
  • 4Sabatine MS, Morrow DA, Higgins LJ, MacGillivray C, Guo W, Bode C, et al. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial Infarction. Circulation 2008; 117: 1936-1944. 被引量:1
  • 5Dhillon OS, Narayan HK, Quinn PA, Squire IB, Davies JE, Ng LL. Interleukin 33 and ST2 in non-ST elevation myocardial infarction: Comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNP. Am Heart J 2011; 61:1163-1170. 被引量:1
  • 6Weir RA, Miller AM, Murphy GE, Clements S, Steedman T, Connell JM, et al. Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction. J Am Coll Cardio12010; 55: 243-250. 被引量:1
  • 7Eggers KM, Armstrong PW, Califf RM, Simoons ML, Venge P, Wallentin L, et al. ST2 and mortality in non-ST-segment elevation acute coronary syndrome. Am Heart J 2010; 159: 788- 794. 被引量:1
  • 8Granger CB, Goldberg R J, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2006;163: 2345-2353. 被引量:1
  • 9Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, et al. IL-33, an interleukin-1 like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23:479- 490. 被引量:1
  • 10Kohli P, Bonaca MP, Kakkar R, Kudinova AY, Scirica BM, Sabatine MS, et al. Role of ST2 innon-st-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial. Clin Chem 2012; 58: 257-266. 被引量:1

共引文献27

同被引文献24

引证文献4

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部